m+Medelevator.RU
← Поиск публикаций
BMC microbiology · 2026

Diagnostic value of nanopore-based targeted sequencing technology for subclinical tuberculosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhu Jianmeng, Shao Su, Zheng Wenhua, Chen Lili, Zhang Ke

Аннотация

BACKGROUND: Subclinical Tuberculosis (TB), with low bacterial loads and non-specific symptoms, is difficult to diagnose and promotes transmission. This study aimed to evaluate the diagnostic performance of nanopore-based targeted sequencing (NTS) for subclinical TB in comparison with Mycobacteria Growth Indicator Tube (MGIT) culture and GeneXpert MTB/RIF (Xpert MTB/RIF) assays.

METHODS: This retrospective research included 103 subclinical TB suspects. We tested sputum, bronchoalveolar lavage fluid, or pleural effusion from each patient using NTS, MGIT culture, and Xpert. Diagnostic performance was assessed using a composite standard.

RESULTS: NTS exhibited higher sensitivity (90.9%) than MGIT culture (40.9%) and Xpert MTB/RIF (50.0%). It had a larger area under the curve (AUC) of 0.923 than Xpert (0.731) and MGIT culture (0.667), as well as an impressive negative predictive value (97.4%) and accuracy (93.2%).

CONCLUSION: NTS efficiently identifies subclinical TB cases with low bacterial burdens using the composite diagnostic criteria, outperforming conventional methods. It could detect TB early, closing the gap in TB control.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты